Alert results for: Commercial genomics Inquiry

Information between 18th June 2021 - 14th March 2024

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Select Committee Documents
Thursday 21st May 2020
Inquiry Publications - Correspondence from Kathy Hibbs, Chief Legal and Regulatory Officer, 23andMe, relating to Commercial genomics follow-up

Commercial genomics - Science, Innovation and Technology Committee
Thursday 21st May 2020
Inquiry Publications - Correspondence from • Avi Lasarow, Chief Executive Officer, DNAfit, relating to Commercial genomics follow-up

Commercial genomics - Science, Innovation and Technology Committee
Monday 1st November 2021
Inquiry Publications - Response to this report

Commercial genomics - Science, Innovation and Technology Committee
Tuesday 22nd June 2021
Inquiry Publications - First Report - Direct-to-consumer genomic testing

Commercial genomics - Science, Innovation and Technology Committee
Thursday 25th June 2020
Written Evidence - UKCloud Ltd
COG0008 - Commercial genomics

Commercial genomics - Science, Innovation and Technology Committee
Wednesday 22nd July 2020
Written Evidence - Department for Health and Social Care
COG0009 - Commercial genomics

Commercial genomics - Science, Innovation and Technology Committee
Thursday 11th June 2020
Written Evidence - Bioindustry Association
COG0005 - Commercial genomics

Commercial genomics - Science, Innovation and Technology Committee
Thursday 11th June 2020
Written Evidence - Genomics plc
COG0003 - Commercial genomics

Commercial genomics - Science, Innovation and Technology Committee
Thursday 11th June 2020
Written Evidence - 23andMe
COG0002 - Commercial genomics

Commercial genomics - Science, Innovation and Technology Committee
Thursday 11th June 2020
Written Evidence - Roche Products Ltd
COG0004 - Commercial genomics

Commercial genomics - Science, Innovation and Technology Committee
Thursday 11th June 2020
Written Evidence - Department of Health and Social Care
COG0006 - Commercial genomics

Commercial genomics - Science, Innovation and Technology Committee
Thursday 25th June 2020
Written Evidence - St Mary's University
COG0007 - Commercial genomics

Commercial genomics - Science, Innovation and Technology Committee
Monday 22nd June 2020
Oral Evidence - Dr Tara Clancy (Council Member at Nuffield Council on Bioethics), Graeme Tunbridge (Director of Devices at Medicines and Healthcare products Regulatory Agency), Lord Bethell (Minister for Innovation at Department of Health and Social Care), and Professor Sir Mark Caulfield (Chief Scientist at Genomics England)
Nuffield Council on Bioethics, Medicines and Healthcare products Regulatory Agency, Department of Health and Social Care, and Genomics England

Commercial genomics - Science, Innovation and Technology Committee